Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2005
10/06/2005US20050220714 Agents for use in magnetic resonance and optical imaging
10/06/2005US20050220713 Masticatory function test wax cube, and method and apparatus for producing the same
10/06/2005US20050220712 Method for determining mucosal neutrophil counts in neutropenia patents
10/06/2005US20050220710 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
10/06/2005US20050220708 Skin test for detecting non-allergic hypersensitivity
10/06/2005US20050220707 piperazine(piperidine)carboxamidine; antidepressant, brain trauma, ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy; varying activities on nitric oxide synthases (NOS), arginine decarboxylases (ADC), and nitrosodimethylamine (NDMA) receptor binding
10/06/2005US20050220706 Tyrosine kinase type 1 family of receptors; cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor
10/06/2005CA2560859A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005CA2560848A1 Method and materials for use in diagnosing viral myocarditis
10/06/2005CA2560508A1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
10/05/2005EP1582539A1 Latex polymer particles containing fluorescent substance or contrast medium and process for producing the same
10/05/2005EP1581262A2 Contrast agent
10/05/2005EP1581047A2 Radiopaque animal chew
10/05/2005EP1301164A4 Improved diagnostic method for detecting dysplastic epithelial tissue
10/05/2005EP1163231B1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
10/05/2005CN1678900A 3-D in-vivo imaging and topography using structured light
10/05/2005CN1678342A Treatment for eye disorder
10/05/2005CN1678303A Keto cannabinoids with therapeutic indications
10/05/2005CN1678297A Method of treating osteoarthritis
10/05/2005CN1678239A Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence
10/05/2005CN1221250C Use of particulate contrast agents in diagnostic imaging for studying physiological parameters
10/05/2005CN1221214C Apparatus and method for making gas-filled utricle of optimal size
10/04/2005US6951756 Closure of bacterial ghost
10/04/2005US6951641 administering a dimeric nonionic X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering allergic conjunctivtis and allergic rhinitis
10/04/2005US6951639 1,4,7,10-tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them
10/04/2005CA2179622C Cascade polymers with iodine aromatic compounds
09/2005
09/29/2005WO2005089814A1 X-ray visible drug delivery device
09/29/2005WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents
09/29/2005WO2005089436A2 Genetic networks regulated by attenuated gh/igf1 signaling and caloric restriction
09/29/2005WO2005089398A2 Method for the delivery of sustained release agents
09/29/2005WO2005089106A2 Degradable nanoparticles
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2004002308A3 Management of gastro-intestinal disorders
09/29/2005US20050215873 Imaging method and device for carrying out said method
09/29/2005US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders
09/29/2005US20050214380 Nanobioprocessor for protein and cell therapy
09/29/2005US20050214223 Abuse-safeguarded dosage form
09/29/2005US20050214222 In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
09/29/2005US20050214221 fluorochrome-conjugated metabolically recognizable molecules (drug) as in vivo nonradiactive metabolite imaging agaent; detection or evaluation of biological processes in near infrared region (co-registered with an image obtained by magnetic resonance or computed tomography imaging)
09/29/2005US20050214220 Tumor model
09/29/2005US20050214219 24p3 receptors and uses thereof
09/29/2005US20050214217 Methods of and pharmaceutical compositions for modulating T-lymphocyte adhesion, migration, gene expression and function by Glutamate and analogs thereof
09/29/2005US20050214216 Diagnostic microspheres
09/29/2005CA2560261A1 Method for the delivery of sustained release agents
09/28/2005EP1579506A2 Water soluble metal and semiconductor nanoparticle complexes
09/28/2005EP1578992A2 Methods of determining precise herg interactions and aletring compounds based on said interactions
09/28/2005EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance
09/28/2005EP1578958A2 Method for suppressing immune system response to transplanted tissue or cells
09/28/2005EP1578945A2 Cct6s as modifiers of the rb pathway and methods of use
09/28/2005EP1578902A2 Neurotransmission-associated proteins
09/28/2005EP1578454A1 Ultrasound contrast using halogenated xanthenes
09/28/2005EP1578453A1 Liquid embolisate
09/28/2005EP1349490A4 Fluorescence-mediated molecular tomography
09/28/2005EP1137766B1 Use of il-12 antibodies to treat psoriasis
09/28/2005EP1039834B1 Optoacoustic contrast agents and methods for their use
09/28/2005CN1675245A Monoclonal antibody hPAM4
09/28/2005CN1674943A Radioactively labelled amino acid analogues, their preparation and use
09/28/2005CN1673252A Terminal amino oxyethylene block polymer modified Gd coordination compound and its synthesis process
09/27/2005US6949690 Methods of assessing the effect of a gene of interest on human prostate cancer progression
09/27/2005US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949338 Methods and kits for obtaining and analyzing skin samples for the detection of nucleic acids
09/27/2005US6949266 Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging
09/27/2005CA2241825C New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
09/22/2005WO2005087943A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
09/22/2005WO2005087367A1 Magnetic composite particle and process for producing the same
09/22/2005WO2005087273A2 Extended-linear polymeric contrast agents and their synthesis
09/22/2005WO2005087272A2 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
09/22/2005WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery
09/22/2005WO2005086639A2 Improved efficacy and safety of targeted particulate agents with decoy systems
09/22/2005WO2005086612A2 Fluorinated carbohydrate conjugates
09/22/2005WO2005072097A9 Toll-like receptor 9 modulators
09/22/2005WO2005030258A3 Small molecule compositions and methods for increasing drug efficiency using compositions thereof
09/22/2005US20050209298 treating rheumatoid arthritis by photodynamic therapy (PDT), by administering an iminochlorin aspartic acid porphyrin derivative called ATX-S10 sodium salt; determining the location of a sentinel lymph node and the presence of cancer metastasis; compounds from US patent 6063777
09/22/2005US20050208535 Using retinol binding protein 4 (RBP4)/transthyretin complex formation as tool in identifying modulators of eating and pancreatic disorders
09/22/2005US20050208470 Toll-like receptor assays
09/22/2005US20050207981 Compositions and methods for determining substrate specificity of hydrolytic enzymes
09/22/2005US20050207980 Stable microbubbles suspensions injectable into living organisms
09/22/2005US20050207979 Process for the production of pharmaceutical preparations
09/22/2005US20050207978 Dental-caries detecting solution
09/22/2005US20050207976 High energy phototherapeutic agents
09/22/2005DE102005013370A1 The test for a malignant disease, and especially prostate cancer, determines the concentration of transformed alpha2 macroglobulins for comparison with a healthy control group
09/22/2005DE102004010387A1 Kontrastmittel für die Röntgen-Computertomographie Contrast agents for X-ray CT
09/22/2005CA2559628A1 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer
09/22/2005CA2559095A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
09/22/2005CA2559062A1 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
09/22/2005CA2557633A1 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
09/22/2005CA2555343A1 Improved efficacy and safety of targeted particulate agents with decoy systems
09/22/2005CA2533878A1 Fluorinated carbohydrate conjugates
09/21/2005EP1576968A2 Dental-caries detecting solution
09/21/2005EP1576138A2 2-branched nucleosides and flaviviridae mutation
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575621A2 Contrast media formulations having improved biological tolerance
09/21/2005EP1575620A2 Bio-degradable microspheres for diagnosing gastroesophagal reflux
09/21/2005EP1575573A2 Agents and methods for treatment of disease by oligosaccharide targeting agents
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575496A2 Colon tumor specific binding peptides
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1404377B1 Improved chelator conjugates
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 354